Приложение. Списки литературы к главам

34. Imyanitov EN. Kuligina E.Sh, Belogubova E.V. et al. Mechanisms of lung cancer // Drug. Discov. Today: Dis. Mech. - 2005 - Vol. 2. - P. 213-223.

35. International Agency for Research on Cancer. Agents classified by the IARC Monographs, Vols. 1-102. Lyon: IARC. http://monographs.iarc.fr/ENG/Classification/index.php . Доступ 03.03.2013

36. International Agency for Research on Cancer. Monographs available in PDF format Suppl 7, Vols. 48-100C. Lyon: IARC. http://monographs.iarc.fr/ENG/Monographs/PDFs/index.php . Доступ 03.03.2013

37. International Agency for Research on Cancer. Monographs Vols.1-47. Lyon: IARC. http://monographs.iarc.fr/ENG/Monographs/allmonos47.php . Доступ 03.03.2013

38. Jayaprakash V., Natarajan K.K., Moysich K.B. et al. Wood dust exposure and the risk of upper aero-digestive and respiratory cancers in males. Occup Environ Med. 2008.-Vol.65. Р.647-654.

39. Kaye F.J. Molecular biology of lung cancer // Lung. Cancer. - 2001. - Vol. 34 (Suppl. 2). - P. 35-41.

40. Kong F.M., Anscher M.S., Washington M.K. et al. M6P/IGF2R is mutated in squamous cell carcinoma of the lung // Oncogene. - 2000. - Vol. 19. - P. 1572-1578.

41. Langard S., Norseth T. A cohort study of bronchial carcinomas in workers producing chromate pigments. Br J Ind Med. 1975.-Vol.32., Р.62-65.

42. Lee WJ, Blair A, Hoppin JA, et al. Cancer incidence among pesticide applicators exposed to chlorpyrifos in the agricultural health study. J Natl Cancer Inst. 2004.-Vol.96., Р.1781-1789.

43. Ma P.C.Jagadeeswaran R.,Jagadeesh S. et al. Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small-cell lung cancer // Cancer. Res. - 2005 - Vol. 65 - P. 1479-1488.

44. McHugh MK, Kachroo S, Liu M, et al. Assessing environmental and occupational risk factors for lung cancer in Mexican-Americans. Cancer Causes Control. 2010.-Vol.21P.2157-2164.

45. Nishioka M, Kohno T, Tani M. et al. MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer // Proc. Natl. Acad. Sci. USA. - 2002. - Vol. 99. - P. 12269-12274.

46. Shigematsu H, Lin L, Takahashi T. et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers // J. Natl. Cancer Inst. - 2005. - Vol. 97. - P. 339-346.

47. Siemiatycki J, Richardson L, Straif K, et al. Listing occupational carcinogens. Environ Health Perspect.- 2004, Vol.112.- P.1447-1459.

48. Simonato L, Vineis P, Fletcher AC. Estimates of the proportion of lung cancer attributable to occupational exposure. Carcinogenesis. 1988.-Vol.9, P.1159-65.

49. Smailyte G, Kurtinaitis J, Andersen A. Mortality and cancer incidence among Lithuanian cement producing workers. Occup Environ Med. 2004.-Vol.61.-Р.529-34.

50. Stephens P., Hunter C, Bignell G et al. Lung cancer: intragenic ERBB2 kinase mutations in tumours // Nature. - 2004. - - Vol. 431. - P. 525-526.

51. WHO. 10 facts on environmental and occupational health and cancer. http://www.who.int/features/factfiles/occupational_health_cancer/en/ Доступ 03.03.2013

Эпидемиология и оценка эффективности лечения больных раком легкого на популяционном уровне

1. Злокачественные новообразования в России в 2011 г. (заболеваемость и смертность) / Ред. В.И. Чиссов, В.В. Старинский, Г.В. Петрова. М.: 2013. - 289 с.

2. Мерабишвили В.М. Выживаемость онкологических больных. Выпуск второй. Часть I. / Под ред. Ю.А. Щербука. СПб.: 2011. - 332 с.